278 related articles for article (PubMed ID: 11253594)
1. The management of non-small-cell lung cancer with oligometastases.
Downey RJ; Ng KK
Chest Surg Clin N Am; 2001 Feb; 11(1):121-32, ix. PubMed ID: 11253594
[TBL] [Abstract][Full Text] [Related]
2. Stage IIIB non-small-cell lung cancer.
Rendina EA; Venuta F; De Giacomo T; Furio Coloni G
Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
Garland L; Robinson LA; Wagner H
Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
[TBL] [Abstract][Full Text] [Related]
4. Palliative therapy for lung cancer.
Bezjak A
Semin Surg Oncol; 2003; 21(2):138-47. PubMed ID: 14508864
[TBL] [Abstract][Full Text] [Related]
5. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
[TBL] [Abstract][Full Text] [Related]
6. Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer. The Canadian Lung Oncology Group.
Ann Thorac Surg; 2001 Feb; 71(2):425-33; discussion 433-4. PubMed ID: 11235682
[TBL] [Abstract][Full Text] [Related]
7. Stage II (N1) lung cancer.
Choy O; Jahan T; Roach M; You L; Jablons D
Chest Surg Clin N Am; 2001 Feb; 11(1):39-59, viii. PubMed ID: 11253600
[TBL] [Abstract][Full Text] [Related]
8. Treatment of stage I lung cancer.
Walsh GL; Pisters KM; Stevens C
Chest Surg Clin N Am; 2001 Feb; 11(1):17-38, vii. PubMed ID: 11253597
[TBL] [Abstract][Full Text] [Related]
9. Multimodality therapy for stage III non-small-cell lung cancer.
Farray D; Mirkovic N; Albain KS
J Clin Oncol; 2005 May; 23(14):3257-69. PubMed ID: 15886313
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
[TBL] [Abstract][Full Text] [Related]
11. Stage II (T3) lung cancer.
Allen MS; Jett JR; Kozelsky TF
Chest Surg Clin N Am; 2001 Feb; 11(1):61-7. PubMed ID: 11253601
[TBL] [Abstract][Full Text] [Related]
12. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
Mamon HJ; Yeap BY; Jänne PA; Reblando J; Shrager S; Jaklitsch MT; Mentzer S; Lukanich JM; Sugarbaker DJ; Baldini EH; Berman S; Skarin A; Bueno R
J Clin Oncol; 2005 Mar; 23(7):1530-7. PubMed ID: 15735128
[TBL] [Abstract][Full Text] [Related]
13. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
14. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.
Uy KL; Darling G; Xu W; Yi QL; De Perrot M; Pierre AF; Waddell TK; Johnston MR; Bezjak A; Shepherd FA; Keshavjee S
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):188-93. PubMed ID: 17599507
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
16. Brain metastases in lung cancer.
Gaspar LE
Expert Rev Anticancer Ther; 2004 Apr; 4(2):259-70. PubMed ID: 15056056
[TBL] [Abstract][Full Text] [Related]
17. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
[TBL] [Abstract][Full Text] [Related]
18. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
[TBL] [Abstract][Full Text] [Related]
20. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
Hoffmann H
Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
